| scholarly article | Q13442814 |
| P356 | DOI | 10.3892/OL.2018.8382 |
| P8608 | Fatcat ID | release_hdmtif24mbbttcgxlm3mfs3gei |
| P932 | PMC publication ID | 5950537 |
| P698 | PubMed publication ID | 29805583 |
| P50 | author | Farhan Ul Haq | Q59708414 |
| P2093 | author name string | Muhammad Saeed | |
| Hazir Rahman | |||
| Noor Muhammad | |||
| Nawab Ali | |||
| Farman Ullah Farman | |||
| P2860 | cites work | E2F4 modulates differentiation and gene expression in hematopoietic progenitor cells during commitment to the lymphoid lineage. | Q50801055 |
| Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer. | Q53045539 | ||
| E2F4 loss suppresses tumorigenesis in Rb mutant mice. | Q54798619 | ||
| Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors | Q73436895 | ||
| Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas | Q79401919 | ||
| Molecular Genetics of Colorectal Cancer | Q82521439 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Genomic structure and mutation screening of the E2F4 gene in human tumors | Q28143600 | ||
| E2F-4, a new member of the E2F transcription factor family, interacts with p107 | Q28240565 | ||
| E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo | Q28240575 | ||
| Control of cell cycle transcription during G1 and S phases | Q28295030 | ||
| E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo | Q28585017 | ||
| Epigenetics in cancer | Q29617139 | ||
| E2F: a link between the Rb tumor suppressor protein and viral oncoproteins | Q29618375 | ||
| MethPrimer: designing primers for methylation PCRs | Q29618664 | ||
| E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells | Q33589421 | ||
| Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. | Q33890688 | ||
| Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. | Q34063326 | ||
| DNA methyltransferases, DNA damage repair, and cancer | Q34298096 | ||
| Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis | Q34947016 | ||
| E2F4 regulatory program predicts patient survival prognosis in breast cancer | Q35000629 | ||
| Emerging roles of E2Fs in cancer: an exit from cell cycle control | Q35009182 | ||
| Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter | Q35019557 | ||
| Overexpression of E2F mRNAs associated with gastric cancer progression identified by the transcription factor and miRNA co-regulatory network analysis | Q35043503 | ||
| Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer | Q35138892 | ||
| Genome-wide analysis reveals DNA methylation markers that vary with both age and obesity | Q35204587 | ||
| Promoter Methylation Status Modulate the Expression of Tumor Suppressor (RbL2/p130) Gene in Breast Cancer | Q35745193 | ||
| E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma | Q36996106 | ||
| Aberrant Promoter Methylation at CpG Cytosines Induce the Upregulation of the E2F5 Gene in Breast Cancer | Q37056909 | ||
| Survival-related profile, pathways, and transcription factors in ovarian cancer | Q37081275 | ||
| MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia | Q37289662 | ||
| Epigenetic regulation in cancer progression | Q38463713 | ||
| Cell cycle-related transformation of the E2F4-p130 repressor complex | Q40375347 | ||
| Identification of twenty-two candidate markers for human osteogenic sarcoma | Q40768894 | ||
| Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation | Q42801645 | ||
| E2F4 deficiency promotes drug-induced apoptosis | Q45196180 | ||
| Preparation of genomic DNA from mammalian tissue | Q46761054 | ||
| Nuclear and cytoplasmic mRNA quantification by SYBR green based real-time RT-PCR. | Q50720123 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 8461-8469 | |
| P577 | publication date | 2018-03-29 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Aberrant promoter methylation status is associated with upregulation of the E2F4 gene in breast cancer | |
| P478 | volume | 15 |
| Q93379565 | Prognostic values of E2F mRNA expression in human gastric cancer | cites work | P2860 |
Search more.